Biotech news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
Week Ahead: WHO and its push for a smoke-free world It should be a fairly quiet week in Washington, D.C., on the healthcare front as everyone recovers from a long weekend of parades, pool openings and backyard barbecues. But that doesn’t mean nothing is happening. May 30: Our requisite opioid item—the House Border and Maritime Security Subcommittee holds a field hearing in Phoenix titled “An unsecure ... Read More
Editorial: Congress, FDA need to change biosimilar rules to lower drug prices Just days after President Donald Trump unveiled his vague and widely panned plan to curb pharmaceutical prices, the Food and Drug Administration quietly approved a biosimilar to compete with a drug that has cost taxpayers at least $50 billion over the past quarter century. Alas, this follow-on biologic will arrive long after use of the original ... Read More
Peddling the pill through packaging For as long as people have been prescribed medication, they have forgotten to follow their doctor’s orders. That’s especially a problem when the pills must be taken every day to work—as is the case with birth control. Birth control pills weren’t always labeled by day of the week. Advertisement At first, they were sold like any other pills, in ... Read More
Plasma from 'Man with the Golden Arm' helped save 2.4 million babies The unique antibodies in James Harrison’s blood helped make him something of an Australian superhero. His regular plasma donations over decades are believed to have helped save 2.4 million babies Down Under. His weekly donations earned the 81-year-old the nickname “The Man With the Golden Arm.” His donated plasma is used to develop a life-saving medication, Anti-D, ... Read More
The Case for Intelligent Design (and Infrastructure) in Life Science Biologics R&D New White Paper from IDC Health Insights examines industry trends, new challenges and emerging capabilities in biologics. With many recent blockbuster patents expiring, the pharmaceutical industry finds itself in the middle of a transformation. Leading life science organizations are updating their business strategies to include the pursuit of a new market opportunity – the discovery and development ... Read More